The US Food and Drug Administration announced on Friday that it has granted de novo marketing authorization to an over-the-counter test for syphilis antibodies manufactured by NowDiagnostics.

Alzpath said Monday that it has signed a licensing agreement with Beckman Coulter Diagnostics for use of the Alzpath phosphorylated-tau 217 antibody in a blood-based test for Alzheimer's disease.

On April 18, Sino Biological Inc., a protein and antibody R&D and production expert, signed a strategic cooperation agreement with Megarobo.

Danaher subsidiary Leica Biosystems said Monday that it secured US Food and Drug Administration 510(k) clearance for its Bond MMR Antibody Panel to help identify potential Lynch syndrome in colorectal cancer patients.

The US Food and Drug Administration this week granted Emergency Use Authorization to Diazyme Laboratories for a SARS-CoV-2 total antibody test.

On November 28th China Biologics public release said that the company's anti-neoconazole monoclonal antibody F61 nasal spray developed by the company was approved for clinical use.

NanoSpot.ai and Athroa subsidiary Opto announced Tuesday a commercial and distribution partnership for European sales of NanoSpot.ai's point-of-care SARS-CoV-2 Total Antibody Test.

Fujirebio announced on Thursday that it is acquiring neurodegenerative disease diagnostic company ADx NeuroSciences for €40 million ($42.1 million).

The US Food and Drug Administration last week granted Emergency Use Authorization for InBios International's SCoV-2 Detect Neutralizing Ab ELISA immunoassay for SARS-CoV-2.

Biotech companies Abacus Diagnostica, Kaivogen, and Labrox announced Tuesday that they are combining to create an in vitro diagnostics firm to develop near-patient antibody and PCR tests for infectious diseases and cancers that could be run from a single device.